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A B S T R A C T
Objectives: To describe the laboratory assays used to investigate a suspected dengue case in summer
2012 in western Greece and to report the public health response.
Design of methods: Samples from the patient were tested for detection of Dengue virus (DENV)
antibodies, NS1 antigen and RNA. Public health professionals interviewed residents of the village, and
blood samples taken from 132 persons were tested for antibodies for DENV and West Nile virus (WNV).
Samples from 10 persons who reported symptoms in the prior 15 days (including 3 persons who had
fever at the time of sampling) were tested for DENV, WNV and additional arboviruses. Entomological
missions were organized in the area of potential exposure to investigate the presence of competent
DENV vectors.
Results: Based on a combination of serological and molecular methods, DENV infection was excluded,
and the problems in the serology, especially in the DENV NS1 antigen, were attributed to interfering
factors. A 6.1% WNV seroprevalence was detected in the region, and phlebovirus IgM and IgG antibodies
were detected in two of three persons who had fever at the time of sampling. Aedes albopictus adult
mosquitoes were present in the region.
Conclusions: A multi-disciplinary ﬁeld and laboratory investigation showed no evidence of DENV
infection. There is a need for industries to improve the immunometric assays to avoid interference with
rheumatoid or other factors, and increased awareness is needed for the evaluation of the diagnostic
assays. The high WNV seroprevalence in the investigated region highlights the need for strengthening
awareness on vector borne diseases. The presence of Ae. albopictus suggests that the possibility of
introduction of DENV exists, and preparedness plans are needed.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Dengue virus (DENV) is a ﬂavivirus (family Flaviviridae)
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).mainly Aedes aegypti, whereas Aedes albopictus is considered a
competent although secondary DENV vector. An estimated 50 to
100 million DENV infections occur annually in 125 countries, and
DENV infection is considered a major public health threat by the
World Health Organization (WHO), as Dengue fever global
incidence has increased 30-fold in the last 50 years.1 The main
symptoms of Dengue fever include fever, myalgia, arthralgia, and
rash, whereas severe cases lead to Dengue hemorrhagic fever or
even Dengue shock syndrome. The disease is endemic in tropicalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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reported annually in travelers returning from these regions. The
last large epidemic in Europe was observed during 1927-28 in
Greece (>80% of the population in the Athens area was affected),
with more than 1,000 reported deaths.2 The possibility of re-
introduction of DENV to Europe exists, in view of the increasing
global travel rates and the wide distribution of its secondary
vector, Ae. albopictus, in more than 16 European countries,3 also
present in the wider region of West Greece since 2003.3
Autochthonous cases of Dengue fever have been reported in
2010 in South France4,5 and Croatia,6 while a large outbreak was
detected in 2012 in Madeira, Portugal,7 suggesting that DENV is an
emerging public health threat for Europe.
Another ﬂavivirus, West Nile virus (WNV), transmitted to
humans mainly by bites of infected Culex spp. mosquitoes, is
widely distributed in the world, causing sporadic cases and
outbreaks. Since 2010, when the virus emerged in Greece,8 up to
2013, 609 human cases (432 of them accompanied by neurological
symptoms) have been observed.9 Cross-reactivity is often seen
among ﬂaviviruses, especially among those belonging to the same
serocomplex.10 In the present study we report the laboratory and
ﬁeld investigation of a suspected autochthonous Dengue case
observed in Greece in 2012.
2. Case report
In late August 2012, an 84-year old male resident of a village in
the municipality of Agrinio, western Greece, presented to a local
private clinic with fever, fatigue, neck pain and weakness of his
lower limbs. Laboratory tests showed elevated bilirubin, throm-
bocytopenia, and leukocytosis. The patient was transferred to a
tertiary care center. His condition deteriorated rapidly, and he died
on the 10th day of hospitalization due to Staphylococcus aureus
septicemia despite adequate antimicrobial treatment and sup-
portive care. During his hospitalization he developed epistaxis (not
thrombocytopenic at the time) that was attributed to a medical
history of Rendu-Weber-Osler syndrome. The patient had not
received blood transfusions or other blood products during the
incubation period, and he did not report any travel beyond the
prefecture of his residence. His past medical history included atrial
ﬁbrillation, for which he was treated with an oral anti-coagulant.
3. Laboratory testing
Since an outbreak of WNV infection was ongoing at the time in
Greece in August 2012, blood and cerebrospinal ﬂuid (CSF) samples
drawn on the 8th day of illness were sent to the National Reference
Laboratory for Arboviruses to be tested for probable WNV infection.
Samples were tested for presence of WNV IgM and IgG antibodies
using ELISA (WNV IgM capture DxSelect and WNV IgG DxSelect,
Focus Diagnostics, Cypress, CA). No WNV IgM and IgG antibodies
were detected in the CSF; a borderline WNV IgM antibody index
(1.6 with cut-off 1.5) was seen in the patient’s serum sample, which
became negative after subtraction of the background).Table 1
Initial laboratory testing results of the suspected Dengue case, Greece, August 2012. C
Sample WNV IgM
before/after subtraction
cut off: 1.5
WNV IgG DENV Ig
cut off: 1
Focus
Diagnostics
Serum 1.6/neg neg Out of
range/ne
CSF neg neg neg Due to the presence of epistaxis and thrombocytopenia in the
patient, samples were additionally tested for DENV IgM and
IgG antibodies using ELISA (DENV IgM capture DxSelect and DENV
IgG DxSelect, Focus Diagnostics, Cypress, CA). No DENV IgM
and IgG antibodies were detected in the CSF; results also were
negative for DENV IgG antibodies in the serum and CSF. A high
positive DENV IgM index (out of range) was seen in the patient’s
serum, which resulted in a negative after subtracting the
background.
Blood and CSF samples were also tested for DENV NS1 antigen
(Platelia Dengue NS1 Ag-ELISA (Biorad Laboratories, Marnes-
La-Coquette, France); CSF was negative, but a positive result was
obtained in the serum sample (3.98, cut-off 1). An NS1 kit was kindly
provided by Focus Diagnostics, and serum and CSF samples results
were negative. The large difference between indices before and after
subtraction of the background in the DENV IgM ELISA prompted
us to repeat the Biorad NS1 antigen assay after treatment of the
patient’s serum with rheumatoid factor (Rf)-absorbent (although it
is not written in the instructions for use) to investigate any
interference with IgM- Rfs, and the result was negative.
Two RT-nested PCRs, one using generic ﬂavivirus primers11 and
a second using DENV-speciﬁc primers,12 as well as a DENV-speciﬁc
real time RT-PCR (reagents kindly provided by Ana Vazquez and
Antonio Tenorio, Spain), were applied on serum and CSF samples
and had negative results. Based on all of the above results, the case
was declared DENV-negative.
Serum samples from another WNV-suspected case tested in
the Department of Microbiology in the University of Athens also
gave borderline WNV IgM and a high DENV IgM antibody index; in
that case the DENV infection was easily excluded, since the DENV
IgM was negative after the background subtraction and the NS1
antigen was negative. Five serum samples from additional WNV-
suspected cases with borderline WNV IgM antibodies were
negative after subtraction of the background, and when tested
for DENV IgM and IgG antibodies and NS1 antigen were all
negative. Table 1
4. Public health response
Immediately after the ﬁrst suspicion of DENV infection, and
before ﬁnalization of the laboratory testing, an active case-ﬁnding
mission was organized by the Hellenic Centre for Disease Control
and Prevention (HCDCP) in the village in western Greece where the
patient lived. Public health (PH) professionals from the HCDCP and
the University of Thessaly, in cooperation with regional PH staff,
visited the area and offered a physical exam for all residents of the
village; the participants were interviewed through a structured
questionnaire aiming to identify persons with possible DENV
infection. A total of 132 persons [57 (43.18%) male] were
examined, focusing on an area up to 200-m radius from the case’s
residence, also including the patient’s relatives. Their median age
was 57 years (range 7-85 years). Ten persons reported fever,
headache, arthralgia, myalgia, nausea, vomiting or upper respira-
tory infection in the last 15 days (3 at the time of examination).SF: cerebrospinal ﬂuid; neg: negative.
M
.0
DENV IgG NS1 antigen
cut off: 1.0
PCR
for ﬂaviviruses and
DENV-speciﬁc
BioRad
g
neg 3.98 neg
neg neg neg
Table 2
IgM and IgG antibodies against four phleboviruses: Toscana virus (TOSV), sandﬂy
fever Naples virus (SFNV), sandﬂy fever Sicilian virus (SFNV) and Cyprus virus
(CYPV) in two febrile persons detected during the epidemiological investigation.
Serum dilution 1:100. T: body temperature; neg: negative; F: female.
No Age Sex T (8C) IgM antibodies IgG antibodies
TOSV SFNV SFSV CYPV TOSV SFNV SFSV CYPV
1 24 F 37.5 - - ++ +++ - - + ++
2 12 F 37.2 - - + + - - + -
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conditions to the National Reference Laboratory for arboviruses.
Serum samples were tested for potential detection of WNV and
DENV IgM and IgG antibodies using the same ELISA methods as for
the patient’s samples. All samples were negative for WNV and
DENV IgM antibodies, while WNV IgG antibodies were detected in
8 (8/131, 6.1%) persons, conﬁrmed by plaque reduction neutrali-
zation test (PRNT90). The ages of these 8 persons ranged from 74 to
84 years (median 79 years).
Sera from the ten persons who reported symptoms in the prior
15 days were also tested for IgM and IgG antibodies against
Chikungunya virus (CHIKV) and phleboviruses by indirect
immunoﬂuorescence assays (Euroimmun, Lu¨beck, Germany).
Regarding phleboviruses, samples were tested for antibodies
against Toscana virus (TOSV), sandﬂy fever Naples virus (SFNV),
sandﬂy fever Sicilian virus (SFSV) and Cyprus virus (CYPV) (Sandﬂy
fever virus Mosaic 1, Euroimmun, Lu¨beck, Germany). CHIKV IgM
and IgG antibodies were not detected. However, phlebovirus
IgM and IgG antibodies were detected in two of the three persons
who had fever at the time of sampling (Table 2), suggesting an acute
phlebovirus infection. An RT-nested PCR using phlebovirus generic
primers13 applied on the patients’ blood samples was negative.
PH staff raised awareness of local clinicians and PH profes-
sionals on the clinical presentation of DENV infection. Information
and communication material was also provided to health
professionals and the public on personal protection measures
against mosquitoes, although this activity was on-going due to the
recent outbreaks of WNV infections (since 20108,14,15]) and the
report of autochthonous malaria cases.16
5. Entomological investigation
Two entomological missions were organized in the area of
potential exposure to investigate the presence of competent DENV
vectors. A team of experts from Benaki Phytopathological Institute
and the HCDCP carried out mosquito ﬁeld surveys in the patient’s
village residential area, and in nearby villages per his reported
movement history. Entomological surveillance detected a variety
of potential mosquito breeding sites, which yielded only Culex spp.
larvae and pupae. In addition, three octenol baited adult traps
(2 Biogents Mosquitaire Plus & 1 BG Sentinel) were placed in the
area surrounding the patient’s residence and a nearby village,
where the patient reportedly spent some of his summer vacation. A
total of 3 Ae. albopictus adult mosquitoes were captured during
the mission, which tested DENV-negative at the Department of
Parasitology, Entomology and Tropical Diseases at the National
School of Public Health. Furthermore, a number of oviposition
traps were placed in the immediate surroundings. Eggs were
collected from all three locations, which after hatching in the
laboratory, were identiﬁed as Ae. albopictus.
6. Discussion
One of the priorities of PH preparedness for emerging
pathogens is the capacity for prompt and accurate diagnosis.The present study illustrates the need for a thorough interdisci-
plinary investigation of a ﬁrst reported case of an emerging
pathogen, as well as the value of a Reference Centre, which, being a
member of the European Network of Imported Viral Diseases
(ENIVD), participated in several external quality control studies,
including those on diagnostics on DENV17,18 and WNV.19
The main problem in ﬂavivirus diagnostics is the extensive
cross-reactivity among members of the family, and, especially,
among members of the same serocomplex. The present report
shows an additional problem: the interference of various factors,
such as the Rf or the heterophilic antibodies, in the performance of
the assays for the detection of WNV and DENV antibodies and the
DENV NS1 antigen. The extremely high index (out of range) of
DENV IgM antibodies observed without the subtraction method
was exceptional. Previous studies on WNV cases have shown no
interfering factors in high IgM positive samples (index value of
>3.5) tested by Focus Diagnostics capture ELISA (MAC-ELISA)20
(which applies also for DENV ELISA). The negative result after
application of the subtraction method (which is suggested by the
manufacturers) facilitated the conclusion that the patient did not
have IgM (and IgG) antibodies against WNV and DENV.
The remaining problem was the positive result of the DENV
NS1 antigen when the Biorad kit was used (the manufacturer reports
no interference with heterophilic antibodies). It is of interest
that when the test was repeated after treatment of the patient’s
serum with Rf-absorbent (for the removal of IgM-Rf rheumatoid
factors), the result was negative, suggesting that further studies are
needed on this topic to investigate the role of Rfs in the NS1 antigen
performance. The problem was solved by the negative result in
NS1 antigen when the Focus kit was used, and by the negative result
of the three PCRs (two nested RT-PCRs and one real-time RT-
PCR).The epidemiological and entomological investigation showed
no evidence of DENV infection in the region, neither in humans nor in
mosquitoes. However, the high WNV seroprevalence detected in the
population sample of the region (6.1%), together with the fact that
only two human cases have been reported from the municipality of
Agrinio (one in 2010 and one in 2012), suggests that some WNV
cases probably went undetected, indicating the continuing need
for increased awareness in the region. The detection of two cases
with phlebovirus infection was not unexpected, since the phlebo-
virus seroprevalence in Greece is high (up to 60%), especially in
the islands and the coastal areas of the mainland21,22; western
Greece, where the cases were detected, is among the regions with
high seroprevalence. Patients with mild symptoms, such as the two
cases in the present study, do not seek medical advice, and remain
undetected. However, phlebovirus infections are not usually
included in the differential diagnosis of summer febrile cases, even
when they present neurological symptoms, and the number of
reported cases is currently very limited.23–26
The capture of Ae. albopictus, although DENV-negative, suggests
that the possibility of re-introduction of DENV to Greece exists
(similar to other southern European countries), and preparedness
plans must be in place. The recent autochthonous dengue case
reported in southern France on Aug 20, 2014, emphasises the
present risk of dengue transmission in Europe in areas where
competent mosquito vectors are established.27
In conclusion, the present case shows that the laboratory
diagnosis of a ﬂavivirus infection presents certain challenges and
that critical evaluation of the results by experts in the ﬁeld is
essential; this applies for all cases, but especially when the
emergence of a pathogen in a new area is suspected. There is a need
for industries to improve the immunometric assays to avoid
interference with RF or heterophilic antibodies, while increased
awareness is needed by laboratories about the vulnerability of
diagnostic assays, especially when only one sample is available.
The present investigation was the trigger for a comprehensive
A. Papa et al. / International Journal of Infectious Diseases 30 (2015) 150–153 153approach to detection of arboviral diseases in the area, which can
serve as a basis for future studies; it was also a good opportunity to
further explore collaborations already formed for the management
of WNV and malaria in Greece regarding the prompt mobilization
of a multi-disciplinary team to a particular area for ﬁeld and
laboratory investigations.
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